Poor prediction of virological outcomes by the interpretation of HIV-1 resistance to didanosine and abacavir using 11 available rule-based algorithms

被引：0
|
作者：
Di Giambenedetto, S
Baldini, F
Cori, C
Rizzo, MG
Cingolani, A
Liuzzi, G
Perno, CF
De Luca, A
Antinori, A
机构：
[1] Catholic Univ, Rome, Italy
[2] INMI Spallanzani, Rome, Italy
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
92
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 18 条
  • [1] A study of seven rule-based algorithms for the interpretation of HIV-1 genotypic resistance data in Thailand
    Poonpiriya, Vongsakorn
    Sungkanuparph, Somnuek
    Leechanachai, Pranee
    Pasomsub, Ekawat
    Watitpun, Chotip
    Chunhakan, Sirichan
    Chantratita, Wasun
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2008, 151 (01) : 79 - 86
  • [2] Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation
    Paredes, Roger
    Tzou, Philip L.
    van Zyl, Gert
    Barrow, Geoff
    Camacho, Ricardo
    Carmona, Sergio
    Grant, Philip M.
    Gupta, Ravindra K.
    Hamers, Raph L.
    Harrigan, Richard
    Jordan, Michael R.
    Kantor, Rami
    Katzenstein, David A.
    Kuritzkes, Daniel R.
    Maldarelli, Frank
    Otelea, Dan
    Wallis, Carole L.
    Schapiro, Jonathan M.
    Shafer, Robert W.
    [J]. PLOS ONE, 2017, 12 (07):
  • [3] Ensemble Classifiers for Predicting HIV-1 Resistance from Three Rule-Based Genotypic Resistance Interpretation Systems
    Raposo, Leticia M.
    Nobre, Flavio F.
    [J]. JOURNAL OF MEDICAL SYSTEMS, 2017, 41 (10)
  • [4] Ensemble Classifiers for Predicting HIV-1 Resistance from Three Rule-Based Genotypic Resistance Interpretation Systems
    Letícia M. Raposo
    Flavio F. Nobre
    [J]. Journal of Medical Systems, 2017, 41
  • [5] Study of resistance using the TRUGENE HIV-1 genotyping system and analysis of agreement between rule-based algorithms and virtual phenotyping
    Nogales, MC
    Serrano, MC
    Bernal, S
    Jarana, R
    de la Rosa, LP
    Fernández-Palacín, A
    Almeida, C
    Martín-Mazuelos, E
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2005, 23 (03): : 149 - 155
  • [6] Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems
    De Luca, A
    Cozzi-Lepri, A
    Perno, CF
    Balotta, C
    Di Giambenedetto, S
    Poggio, A
    Pagano, G
    Tositti, G
    Piscopo, R
    Del Forno, A
    Chiodo, F
    Magnanio, G
    Monforte, AD
    [J]. ANTIVIRAL THERAPY, 2004, 9 (05) : 743 - 752
  • [7] Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score
    De Luca, Andrea
    Di Giambenedetto, Simona
    Maserati, Renato
    Gianotti, Nicola
    Narciso, Pasquale
    Antinori, Andrea
    Di Perri, Giovanni
    Prosperi, Mattia C. F.
    Baldanti, Fausto
    Micheli, Valeria
    Zazzi, Maurizio
    Perno, Carlo F.
    Santoro, Maria M.
    [J]. ANTIVIRAL THERAPY, 2011, 16 (04) : 489 - 497
  • [8] Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time
    Frentz, Dineke
    Boucher, Charles A. B.
    Assel, Matthias
    De Luca, Andrea
    Fabbiani, Massimiliano
    Incardona, Francesca
    Libin, Pieter
    Manca, Nino
    Mueller, Viktor
    Nuallain, Breanndan O.
    Paredes, Roger
    Prosperi, Mattia
    Quiros-Roldan, Eugenia
    Ruiz, Lidia
    Sloot, Peter M. A.
    Torti, Carlo
    Vandamme, Anne-Mieke
    Van Laethem, Kristel
    Zazzi, Maurizio
    van de Vijver, David A. M. C.
    [J]. PLOS ONE, 2010, 5 (07):
  • [9] Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes
    De Luca, A
    Vendittelli, M
    Boldini, F
    Di Giambenedetto, S
    Trotta, MP
    Cingolani, A
    Bacarelli, A
    Gori, C
    Perno, CF
    Antinori, A
    Ulivi, G
    [J]. ANTIVIRAL THERAPY, 2004, 9 (04) : 583 - 593
  • [10] Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?
    M. L. Mzingwane
    C. T. Tiemessen
    K. L. Richter
    S. H. Mayaphi
    G. Hunt
    S. M. Bowyer
    [J]. Virology Journal, 13
12